Asia-Pacific Shapes Innovation Push Amid ‘Tsunami’ Of Aging
Executive Summary
Asia-Pacific's growing aging population is expected to bring with it multiple challenges including a higher burden of non-communicable diseases. But health innovations, including crowd-sourced initiatives, could play a key role in improving the "health span" of the silver generation, experts at a recent conference in Singapore suggested.
You may also be interested in...
Bayer Remains Bullish On Asia After Solid Year
Regional uptake of its innovative medicines drove Bayer to another year of solid growth in the Asia-Pacific region, where the German group sees continued prospects given demographic patterns and unmet needs.
How Sanofi Is ‘Playing To Win’ In India, Watch Diabetes Space
Sanofi India managing director Rodolfo Hrosz talks to Scrip about the company’s refreshed India strategy including in the competitive diabetes segment, which is expected to see a flurry of new product activity. While Soliqua has hit the market, all eyes are also on Novo Nordisk’s Awiqli and Cipla’s partnered inhaled insulin in the wings.
Asia Deal Watch: Nippon Shinyaku Takes On Intractable Rare Disease With MiNA
Plus deals involving Incyte/CMS, Biocytogen/ABL, Bharat/Biofabri/Bilthoven, Dr. Reddy’s/Pharmazz, Veeda/Heads, Sosei Heptares/GSK, BioGeometry/Sanyou, Ono/Sibylla and Teijin/BioProjet